Duchenne muscular dystrophy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 3 years old <= age <= 18 years old; 2. Male patients diagnosed with DMD by muscle biopsy or genetic testing; 3. Patients can communicate verbally or non-verbally; 4. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. The patient has a virus infection or a history of virus infection that the investigator believes will affect the clinical trial; 2. The patient has a history of serious infection in the past six months; 3. Patients with respiratory failure who need assisted ventilation; 4. Subjects who have received any other clinical trials within 3 months before the patient's enrollment; 5. The patient or guardian cannot understand the informed consent and the purpose of the research; 6. Life expectancy is less than 24 months; 7. The investigator believes that there may be any situation that increases the risk of the subject or interferes with the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| High Mobility Box B1;Hydroxyproline;miR-483-3p;miR-146a-5p;miR-217;miR-3150a-5p;miR-4707-5p; | — |
Secondary
| Measure | Time frame |
|---|---|
| Exercise evaluation;MRI of both thigh muscles; | — |
Countries
China
Contacts
The Second Hospital of Shanxi Medical University